{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:07:16Z","timestamp":1794002836998,"version":"4.8.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council UK","doi-asserted-by":"crossref","award":["MC-A656\u20135QD30"],"award-info":[{"award-number":["MC-A656\u20135QD30"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wellcome Trust","award":["094849\/Z\/10\/Z"],"award-info":[{"award-number":["094849\/Z\/10\/Z"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Psychiatry"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/s2215-0366(15)00540-4","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T09:23:54Z","timestamp":1457169834000},"page":"451-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Brain-imaging studies of treatment-resistant schizophrenia: a systematic review"],"prefix":"10.1016","volume":"3","author":[{"given":"Elias","family":"Mouchlianitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McCutcheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver D","family":"Howes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2215-0366(15)00540-4_bib1","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(13)62036-X","article-title":"Schizophrenia: an integrated sociodevelopmental-cognitive model","volume":"383","author":"Howes","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2215-0366(15)00540-4_bib2","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.2174\/138161209788957528","article-title":"Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging","volume":"15","author":"Howes","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/S2215-0366(15)00540-4_bib3","first-page":"e07","article-title":"Addressing nonresponse in schizophrenia","volume":"73","author":"Kane","year":"2012","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/YIC.0b013e32836508e6","article-title":"The social and economic burden of treatment-resistant schizophrenia: a systematic literature review","volume":"29","author":"Kennedy","year":"2014","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/S2215-0366(15)00540-4_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0920-9964(00)00144-4","article-title":"Duration of untreated psychosis predicts treatment outcome in an early psychosis program","volume":"47","author":"Black","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/070674371005501007","article-title":"Where to position clozapine: re-examining the evidence","volume":"55","author":"Agid","year":"2010","journal-title":"Can J Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/acps.12327","article-title":"The practical management of refractory schizophrenia\u2014the Maudsley Treatment Review and Assessment Team service approach","volume":"130","author":"Beck","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S2215-0366(15)00540-4_bib9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1192\/bjp.bp.111.105833","article-title":"Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation","volume":"201","author":"Howes","year":"2012","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib11","series-title":"Psychosis and schizophrenia in adults: prevention and management","year":"2014"},{"key":"10.1016\/S2215-0366(15)00540-4_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1192\/bjp.bp.111.105833","article-title":"Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation","volume":"201","author":"Howes","year":"2012","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"10.1016\/S2215-0366(15)00540-4_bib13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.npp.1300312","article-title":"Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex","volume":"29","author":"Lahti","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S2215-0366(15)00540-4_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pnpbp.2007.08.017","article-title":"Differential clinical, structural and P300 parameters in schizophrenia patients resistant to conventional neuroleptics","volume":"32","author":"Molina","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv016","article-title":"Extensive gray matter volume reduction in treatment-resistant schizophrenia","author":"Anderson","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/S2215-0366(15)00540-4_bib16","doi-asserted-by":"crossref","first-page":"325052","DOI":"10.1155\/2014\/325052","article-title":"Patients with poor response to antipsychotics have a more severe pattern of frontal atrophy: a voxel-based morphometry study of treatment resistance in schizophrenia","volume":"2014","author":"Quarantelli","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/S2215-0366(15)00540-4_bib17","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1038\/npp.2015.90","article-title":"Progressive brain atrophy and cortical thinning in schizophrenia after commencing clozapine treatment","volume":"40","author":"Ahmed","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S2215-0366(15)00540-4_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/hipo.20873","article-title":"Hippocampal volumetrics in treatment-resistant depression and schizophrenia: the devil's in de-tail","volume":"22","author":"Maller","year":"2012","journal-title":"Hippocampus"},{"key":"10.1016\/S2215-0366(15)00540-4_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pnpbp.2013.11.015","article-title":"Source-based morphometry of gray matter volume in patients with schizophrenia who have persistent auditory verbal hallucinations","volume":"50","author":"Kubera","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.schres.2013.05.002","article-title":"Reduced dorso-lateral prefrontal cortex in treatment resistant schizophrenia","volume":"148","author":"Zugman","year":"2013","journal-title":"Schizophr Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0447.2009.01389.x","article-title":"Morphology of the corpus callosum in treatment-resistant schizophrenia and major depression","volume":"120","author":"Sun","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S2215-0366(15)00540-4_bib22","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/npp.2013.294","article-title":"Altered interhemispheric and temporal lobe white matter microstructural organization in severe chronic schizophrenia","volume":"39","author":"Holleran","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S2215-0366(15)00540-4_bib23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.schres.2014.10.047","article-title":"Resting-state functional connectivity alterations in the default network of schizophrenia patients with persistent auditory verbal hallucinations","volume":"161","author":"Alonso-Sol\u00eds","year":"2015","journal-title":"Schizophr Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib24","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.biopsych.2009.11.017","article-title":"Auditory hallucinations in schizophrenia are associated with reduced functional connectivity of the temporo-parietal area","volume":"67","author":"Vercammen","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1503\/jpn.110008","article-title":"Dysconnectivity of multiple resting-state networks in patients with schizophrenia who have persistent auditory verbal hallucinations","volume":"36","author":"Wolf","year":"2011","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/S2215-0366(15)00540-4_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pscychresns.2006.12.011","article-title":"A preliminary fMRI study of the effects on cortical activation of the treatment of refractory auditory hallucinations with rTMS","volume":"155","author":"Fitzgerald","year":"2007","journal-title":"Psychiatry Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.schres.2011.11.018","article-title":"Magnetic resonance perfusion imaging of auditory verbal hallucinations in patients with schizophrenia","volume":"134","author":"Wolf","year":"2012","journal-title":"Schizophr Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00406-012-0368-x","article-title":"Individualized rTMS neuronavigated according to regional brain metabolism ((18)FGD PET) has better treatment effects on auditory hallucinations than standard positioning of rTMS: a double-blind, sham-controlled study","volume":"263","author":"Klirova","year":"2013","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/S2215-0366(15)00540-4_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0920-9964(96)00115-6","article-title":"Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET study","volume":"25","author":"Molina Rodr\u00edguez","year":"1997","journal-title":"Schizophr Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0925-4927(97)00057-7","article-title":"Fronto-striato-thalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. A 99mTc-HMPAO study","volume":"76","author":"Molina Rodr\u00edguez","year":"1997","journal-title":"Psychiatry Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.pnpbp.2007.12.028","article-title":"Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients","volume":"32","author":"Molina","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2190\/1AA0-UW9Q-1CNK-3E2N","article-title":"The effects of clozapine on cognitive function and regional cerebral blood flow in the negative symptom profile schizophrenia","volume":"36","author":"Zhao","year":"2006","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/S2215-0366(15)00540-4_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2007-984399","article-title":"Marked hypofrontality in clozapine-responsive patients","volume":"40","author":"Molina","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib34","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","article-title":"Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function","volume":"75","author":"Demjaha","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib35","doi-asserted-by":"crossref","first-page":"pyu117","DOI":"10.1093\/ijnp\/pyu117","article-title":"Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia","volume":"18","author":"Goldstein","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/S2215-0366(15)00540-4_bib36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.euroneuro.2005.03.001","article-title":"Clozapine improves working memory updating in schizophrenia","volume":"15","author":"Galletly","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/S2215-0366(15)00540-4_bib37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.schres.2010.11.028","article-title":"MMN responsivity to manipulations of frequency and duration deviants in chronic, clozapine-treated schizophrenia patients","volume":"126","author":"Horton","year":"2011","journal-title":"Schizophr Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib38","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0006-3223(97)00524-6","article-title":"Effects of clozapine on auditory event-related potentials in schizophrenia","volume":"44","author":"Umbricht","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bandc.2004.02.045","article-title":"ERP study of pre-attentive auditory processing in treatment-refractory schizophrenia","volume":"55","author":"Milovan","year":"2004","journal-title":"Brain Cogn"},{"key":"10.1016\/S2215-0366(15)00540-4_bib40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1192\/bjp.167.2.202","article-title":"Magnetic resonance imaging and single photon emission tomography in treatment-responsive and treatment-resistant schizophrenia","volume":"167","author":"Lawrie","year":"1995","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib41","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2004.02.011","article-title":"Volume of the cingulate and outcome in schizophrenia","volume":"72","author":"Mitelman","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1176\/ajp.155.3.337","article-title":"Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients","volume":"155","author":"Bartlett","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib43","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1176\/appi.ajp.2012.12010144","article-title":"Dopamine synthesis capacity in patients with treatment-resistant schizophrenia","volume":"169","author":"Demjaha","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3109\/00207450108986524","article-title":"Abnormal EEG patterns in treatment-resistant schizophrenic patients","volume":"109","author":"Ramos","year":"2001","journal-title":"Int J Neurosci"},{"key":"10.1016\/S2215-0366(15)00540-4_bib45","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.clinph.2014.07.017","article-title":"A machine learning approach using auditory odd-ball responses to investigate the effect of clozapine therapy","volume":"126","author":"Ravan","year":"2015","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/S2215-0366(15)00540-4_bib46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.schres.2005.11.025","article-title":"Quantitative EEG and low resolution electromagnetic tomography (LORETA) imaging of patients with persistent auditory hallucinations","volume":"83","author":"Lee","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4306\/pi.2008.5.2.115","article-title":"Nonlinear analysis of electroencephalogram in schizophrenia patients with persistent auditory hallucination","volume":"5","author":"Lee","year":"2008","journal-title":"Psychiatry Investig"},{"key":"10.1016\/S2215-0366(15)00540-4_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0893-133X(95)00017-8","article-title":"Regional cortical anatomy and clozapine response in refractory schizophrenia","volume":"13","author":"Honer","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S2215-0366(15)00540-4_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0920-9964(00)00130-4","article-title":"Prefrontal cortical sulcal widening associated with poor treatment response to clozapine","volume":"48","author":"Konicki","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib50","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0006-3223(91)90053-O","article-title":"Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia","volume":"29","author":"Friedman","year":"1991","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib51","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1176\/appi.ajp.160.8.1421","article-title":"The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes","volume":"160","author":"Arango","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0925-4927(03)00108-2","article-title":"Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia","volume":"124","author":"Molina","year":"2003","journal-title":"Psychiatry Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib53","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0006-3223(97)00491-5","article-title":"Association between regional brain volumes and clozapine response in schizophrenia","volume":"43","author":"Lauriello","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib54","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0140-6736(95)90441-7","article-title":"Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine","volume":"345","author":"Chakos","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/S2215-0366(15)00540-4_bib55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0893-133X(00)00172-X","article-title":"The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics","volume":"24","author":"Scheepers","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S2215-0366(15)00540-4_bib56","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1176\/appi.ajp.158.4.644","article-title":"Effect of clozapine on caudate nucleus volume in relation to symptoms of schizophrenia","volume":"158","author":"Scheepers","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib57","first-page":"155","article-title":"Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia","volume":"6","author":"Buchsbaum","year":"1992","journal-title":"Neuropsychopharmacology"},{"issue":"suppl B","key":"10.1016\/S2215-0366(15)00540-4_bib58","first-page":"63","article-title":"Clozapine effects on glucose metabolic rate in striatum and frontal cortex","volume":"55","author":"Potkin","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib59","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1176\/ajp.153.10.1343","article-title":"SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine","volume":"153","author":"Molina Rodr\u00edguez","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib60","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.neuroimage.2007.08.049","article-title":"Cortical folding abnormalities in schizophrenia patients with resistant auditory hallucinations","volume":"39","author":"Cachia","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/S2215-0366(15)00540-4_bib61","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pscychresns.2009.04.007","article-title":"The effect of clozapine on regional cerebral blood flow and brain metabolite ratios in schizophrenia: relationship with treatment response","volume":"174","author":"Ertugrul","year":"2009","journal-title":"Psychiatry Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib62","first-page":"35","article-title":"Evaluation of SISCOM in routine regional cerebral blood flow alterations after clozapine, in schizophrenia","volume":"13","author":"Erg\u00fcn","year":"2010","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/S2215-0366(15)00540-4_bib63","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0006-3223(02)01602-5","article-title":"Functional effects of antipsychotic drugs: comparing clozapine with haloperidol","volume":"53","author":"Lahti","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib64","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.mp.4001191","article-title":"D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine","volume":"8","author":"Potkin","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib65","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0278-5846(95)00116-D","article-title":"Quantified EEG changes associated with a positive clinical response to clozapine in schizophrenia","volume":"19","author":"Lacroix","year":"1995","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib66","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1037\/1064-1297.10.4.435","article-title":"EEG coherence following acute and chronic clozapine in treatment-resistant schizophrenics","volume":"10","author":"Knott","year":"2002","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/S2215-0366(15)00540-4_bib67","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2004-818989","article-title":"Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study","volume":"37","author":"Gross","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0920-9964(00)00165-1","article-title":"Quantitative EEG in schizophrenia and in response to acute and chronic clozapine treatment","volume":"50","author":"Knott","year":"2001","journal-title":"Schizophr Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib69","doi-asserted-by":"crossref","first-page":"596486","DOI":"10.5402\/2012\/596486","article-title":"Clozapine augments delta, theta, and right frontal EEG alpha power in schizophrenic patients","volume":"2012","author":"MacCrimmon","year":"2012","journal-title":"ISRN Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib70","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2147\/NDT.S69784","article-title":"Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia","volume":"10","author":"Kikuchi","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/S2215-0366(15)00540-4_bib71","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-004-1981-9","article-title":"Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement","volume":"178","author":"Molina","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/S2215-0366(15)00540-4_bib72","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pscychresns.2005.07.004","article-title":"Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder","volume":"140","author":"Hoptman","year":"2005","journal-title":"Psychiatry Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib73","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/WNP.0000000000000145","article-title":"Sleep EEG and spindle characteristics after combination treatment with clozapine in drug-resistant schizophrenia: a pilot study","volume":"32","author":"Tsekou","year":"2015","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/S2215-0366(15)00540-4_bib74","first-page":"62","article-title":"Clozapine in treatment-resistant schizophrenics","volume":"24","author":"Kane","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/S2215-0366(15)00540-4_bib75","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00001756-200401190-00030","article-title":"Gamma\/beta oscillation and sensory gating deficit in schizophrenia","volume":"15","author":"Hong","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/S2215-0366(15)00540-4_bib76","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00213-012-2953-0","article-title":"The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory: a dual [(11)C]raclopride and [(18)\u2008F]FDG imaging study with aripiprazole","volume":"227","author":"Kim","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/S2215-0366(15)00540-4_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1192\/bjp.bp.113.138578","article-title":"A neurobiological hypothesis for the classification of schizophrenia: type A (hyperdopaminergic) and type B (normodopaminergic)","volume":"205","author":"Howes","year":"2014","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(98)00094-2","article-title":"Mapping of grey matter changes in schizophrenia","volume":"35","author":"Wright","year":"1999","journal-title":"Schizophr Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib79","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2174\/138920112800784961","article-title":"The glutamate hypothesis of schizophrenia: neuroimaging and drug development","volume":"13","author":"Egerton","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/S2215-0366(15)00540-4_bib80","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2174\/138161212799316244","article-title":"Glutamate and psychosis risk","volume":"18","author":"Egerton","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/S2215-0366(15)00540-4_bib81","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","article-title":"Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses","volume":"51","author":"Krystal","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib82","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia","volume":"31","author":"Lisman","year":"2008","journal-title":"Trends Neurosci"},{"key":"10.1016\/S2215-0366(15)00540-4_bib83","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S2215-0366(15)00540-4_bib84","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"17","author":"Moghaddam","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/S2215-0366(15)00540-4_bib85","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(98)00067-0","article-title":"Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis","volume":"20","author":"Newcomer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S2215-0366(15)00540-4_bib86","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/mp.2011.171","article-title":"Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology","volume":"17","author":"Stone","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib87","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1177\/0269881109106959","article-title":"Review: the biological basis of antipsychotic response in schizophrenia","volume":"24","author":"Stone","year":"2010","journal-title":"J Psychopharmacol"},{"key":"10.1016\/S2215-0366(15)00540-4_bib88","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptor dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1176\/appi.ajp.2014.14040435","article-title":"Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies","volume":"172","author":"Arnedo","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib90","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.schres.2014.10.048","article-title":"The effect of lifetime adversities on resistance to antipsychotic treatment in schizophrenia patients","volume":"161","author":"Hassan","year":"2015","journal-title":"Schizophr Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib91","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/mp.2014.56","article-title":"Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients","volume":"20","author":"Frank","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib92","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pnpbp.2015.06.015","article-title":"Identification of two clusters within schizophrenia with different structural, functional and clinical characteristics","volume":"64","author":"Lubeiro","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib93","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/schbul\/sbr017","article-title":"Abnormal relationship between medial temporal lobe and subcortical dopamine function in people with an ultra high risk for psychosis","volume":"38","author":"Allen","year":"2012","journal-title":"Schizophr Bull"},{"key":"10.1016\/S2215-0366(15)00540-4_bib94","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/mp.2009.108","article-title":"Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis","volume":"16","author":"Fusar-Poli","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib95","first-page":"438","article-title":"Volumetric changes in the basal ganglia after antipsychotic monotherapy: a systematic review","volume":"20","author":"Ebdrup","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/S2215-0366(15)00540-4_bib96","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","article-title":"Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia","volume":"68","author":"Ho","year":"2011","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib97","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/sj.npp.1300710","article-title":"The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys","volume":"30","author":"Dorph-Petersen","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S2215-0366(15)00540-4_bib98","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/00001756-200205070-00019","article-title":"Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic action","volume":"13","author":"Kapur","year":"2002","journal-title":"Neuroreport"},{"key":"10.1016\/S2215-0366(15)00540-4_bib99","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0022-3956(97)00052-6","article-title":"The natural history and pathophysiology of treatment resistant schizophrenia","volume":"32","author":"Sheitman","year":"1998","journal-title":"J Psychiatr Res"},{"key":"10.1016\/S2215-0366(15)00540-4_bib100","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1523\/JNEUROSCI.5416-06.2007","article-title":"\u201cBreakthrough\u201d dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time","volume":"27","author":"Samaha","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/S2215-0366(15)00540-4_bib101","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S2215-0366(15)00540-4_bib102","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Goff","year":"2001","journal-title":"Am J Psychiatry"}],"container-title":["The Lancet Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215036615005404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215036615005404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T11:10:11Z","timestamp":1589627411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2215036615005404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S2215036615005404"],"URL":"https:\/\/doi.org\/10.1016\/s2215-0366(15)00540-4","relation":{},"ISSN":["2215-0366"],"issn-type":[{"value":"2215-0366","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain-imaging studies of treatment-resistant schizophrenia: a systematic review","name":"articletitle","label":"Article Title"},{"value":"The Lancet Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2215-0366(15)00540-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}